Dr, Ran Reshef, one of the newest principal investigators at the CCTI and an expert in blood cancers such as leukemia, lymphoma and myeloma, has been profiled by the Conquer Cancer Foundation. In his profile, Dr. Reshef discusses the work he is doing at the CCTI, with the assitance of a Conquer Cancer Foundation Career Development Award, and strategies to prevent graft-vs-host disease *(GVHD) to help improve survival rates in transplant recipients. Click here for the full story.